Compare VRDN & EXK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VRDN | EXK |
|---|---|---|
| Founded | 2006 | 1981 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.4B |
| IPO Year | N/A | N/A |
| Metric | VRDN | EXK |
|---|---|---|
| Price | $31.17 | $9.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 4 |
| Target Price | ★ $40.45 | $11.69 |
| AVG Volume (30 Days) | 1.4M | ★ 14.4M |
| Earning Date | 11-05-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $70,789,000.00 | ★ $337,137,000.00 |
| Revenue This Year | $26,257.62 | $111.57 |
| Revenue Next Year | $10.69 | $64.09 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 23340.07 | 49.22 |
| 52 Week Low | $9.90 | $2.95 |
| 52 Week High | $34.04 | $10.37 |
| Indicator | VRDN | EXK |
|---|---|---|
| Relative Strength Index (RSI) | 50.76 | 53.73 |
| Support Level | $30.57 | $9.28 |
| Resistance Level | $32.92 | $10.07 |
| Average True Range (ATR) | 0.98 | 0.57 |
| MACD | -0.39 | -0.02 |
| Stochastic Oscillator | 19.02 | 43.38 |
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
Endeavour Silver Corp is a Canadian mineral company engaged in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. The Company has two operating mining segments which are located in Mexico, Guanacevi and Bolanitos. The company has one development project in Mexico, Terronera, as well as Exploration and Corporate segments. The Exploration segment consists of projects in the exploration and evaluation phases in Mexico, Chile, and the USA.